ArticleAdvances in neural information processing systems2023
Estimating and Controlling for Equalized Odds via Sensitive Attribute Predictors.
Article in Advances in neural information processing systems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
As the use of machine learning models in real world high-stakes decision settings continues to grow, it is highly important that we are able to audit and control for any potential fairness violations these models may exhibit towards certain groups. To do so, one naturally requires access to sensitive attributes, such as demographics, biological sex, or other potentially sensitive features that determine group membership. Unfortunately, in many settings, this information is often unavailable. In this work we study the well
Identifiers
38867889PMC11167624What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.